Dec 31, 2025 • MarketBeat
SOMEWHAT-BULLISH
JB Capital LLC Boosts Holdings in Merck & Co., Inc. $MRK
JB Capital LLC increased its stake in Merck & Co., Inc. by 11.5% in the third quarter, now holding 127,915 shares valued at approximately $10.74 million. Other major institutions also adjusted their positions, and around 76.07% of Merck's stock is institutionally owned. Merck recently raised its quarterly dividend to $0.85 per share, resulting in an annualized dividend of $3.40 and a yield of 3.2%.
Dec 31, 2025 • MarketBeat
NEUTRAL
Ameren Corporation $AEE Stake Cut by Pacer Advisors Inc.
Pacer Advisors Inc. significantly reduced its stake in Ameren Corporation (NYSE:AEE) by 42.0% in the third quarter, now holding 22,792 shares valued at approximately $2.379 million. Despite this, other major institutional investors like Vanguard, AllianceBernstein, JPMorgan, Invesco, and Franklin Resources increased their positions in the utility provider. Ameren reported strong Q3 earnings, beating analyst estimates, and provided positive FY2025 and FY2026 guidance, alongside an announced quarterly dividend.
Dec 31, 2025 • MarketBeat
SOMEWHAT-BULLISH
Calamos Advisors LLC Has $26.30 Million Stake in SLB Limited $SLB
Calamos Advisors LLC significantly increased its stake in SLB Limited (NYSE:SLB) by 134.0% in the third quarter, bringing its total holdings to 765,234 shares valued at over $26 million. Other major institutional investors like Vanguard Group Inc. and Franklin Resources Inc. also expanded their positions in the oil and gas company. Analysts currently rate SLB as a "Moderate Buy" with a consensus price target of $52.42, following recent upgrades and price objective revisions.
Dec 31, 2025 • MarketBeat
NEUTRAL
Calamos Advisors LLC Grows Stock Position in Thermo Fisher Scientific Inc. $TMO
Calamos Advisors LLC significantly increased its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 41.8% in Q3, now owning 147,700 shares valued at approximately $71.64 million. Despite this, company insiders have been net sellers, with CEO Marc N. Casper selling 17,104 shares and VP Lisa P. Britt selling 10,225 shares. The medical research company reported strong Q3 earnings, beating expectations, and authorized a $5.0 billion share buyback program.
Dec 31, 2025 • MarketBeat
SOMEWHAT-BULLISH
Allspring Global Investments Holdings LLC Lowers Stake in Labcorp Holdings Inc. $LH
Allspring Global Investments Holdings LLC reduced its stake in Labcorp Holdings Inc. by 0.2% in the third quarter, while still holding a significant position. Insiders, including Director Richelle P. Parham and CEO Adam H. Schechter, also sold shares, decreasing insider ownership to about 0.84%. Labcorp exceeded Q3 EPS estimates, saw an 8.6% increase in revenue, and set strong FY2025 guidance, with analysts maintaining a "Moderate Buy" rating and a consensus target price of nearly $299.
Dec 30, 2025 • Stock Titan
NEUTRAL
[N-CSR] PUTNAM MANAGED MUNICIPAL INCOME TRUST SEC Filing
Putnam Managed Municipal Income Trust (PMM) released its annual report for the fiscal year ended October 31, 2025, detailing its investment performance and financial position. The closed-end municipal bond fund reported a total return of +3.16% based on net asset value and +2.06% based on market price. The report also highlights the fund's managed distribution plan and significant investments in municipal bonds across various U.S. states and territories.